BDSX
Biodesix Inc
$21.87
▲ +3.16%
+$0.67
NASDAQ · Healthcare · Diagnostics & Research
· price updated 9h ago
Biodesix Inc
BDSX · NASDAQ · Healthcare · Diagnostics & Research · price updated 9h ago
$21.87
▲ +3.16% · +$0.67 today
AI research · $21.87
Track BDSX for continuous AI research
price position
Where BDSX sits now
52-week range
Low$5.26
High$24.92
Today $21.87
RSI (14)
55.9Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$25.6M
Total debt$71.6M
Net cash after debt$-46.0M
Valuation
What the market charges
Forward P/E
Price against expected earnings
No signal · Not enough data to judge
-
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.28x
Price / FCF
Price against free cash generation
No signal · Not enough data to judge
-
EV / EBITDA
Operating value including debt
No signal · Not enough data to judge
-
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
-20.1%
ROE
Profit generated from shareholder equity
Weak · Below 10% return on equity
-316.5%
Debt / equity
Balance-sheet leverage
Rich · Debt is above 1.5x equity
8.06x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
2.82x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How BDSX compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $219.54M | - | +29.1% | - |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Biodesix Inc (BDSX) stock
Biodesix Inc trades on NASDAQ under the ticker BDSX. BDSX was +3.2% in the latest available session at $21.87. Its reported market value was $219.54M with a trailing P/E of 0.0. Latest reported revenue was $96.10M, changing +29.1% year over year, with $-31.96M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $21.87
- Day change
- +3.2%
- Market cap
- $219.54M
- P/E (TTM)
- 0.0
- Revenue growth
- +29.1%
- Industry
- Diagnostics & Research